There are numerous medical disorders that are known to heighten the risk of traffic collision and put drivers in serious danger. This important subject has persuaded governments to make legal solutions to deal with drivers who have these disorders. In order to acquire or renew a driving license, drivers must prove that they have no serious medical disorders which could impair their driving ability, or that they have taken the sufficient precautions to ensure adequate driving ability.
Obstructive sleep apnea (OSA) is one of these medical disorders and is related to excessive daytime sleepiness (EDS).1 It is a curable condition that can be successfully treated using continuous positive airway pressure (CPAP).2 OSA is an important risk factor for traffic collision.3 However, only a few countries, mostly in the European Union, require OSA screening prior to receiving or renewing a driving license.4
Despite the fact that the diagnosis of OSA and its dangerous consequences for driving have an important role in increasing safety on the road, screening for it is still not common practice. One significant problem is that OSA in drivers is generally evaluated by questionnaires, which are susceptible to reporting bias, because drivers usually seek to underestimate their OSA severity.5 However, the problem can be easily solved as objective evaluation by polysomnography or portable monitoring device at sleep clinics can confirm the diagnosis of OSA and define its severity. 3,6
It is very important to add the mandatory screening for OSA to the driving license application procedure, in which drivers who are suspected of having OSA must be referred to authorized sleep clinics for further evaluations before a driving license is issued. Suspect OSA sufferers must be advised not to drive until the OSA screening results are known. Drivers with moderate or severe OSA must receive appropriate treatment under medical insurance coverage. Licenses could be issued to drivers with OSA who have sufficient control of their condition and whose symptoms improve with appropriate treatment. This treatment must be administered by authorized sleep clinics. Drivers receiving treatment for OSA must be evaluated at regular intervals to determine the level of compliance with the treatment and its necessary continuation.
Footnotes
Funding: None.
Competing interests: None declared.
Ethical approval: Not required.
References
- 1.Khazaie H, Najafi F, Rezaie L, Tahmasian M, Sepehry AA, Herth FJ. Prevalence of symptoms and risk of obstructive sleep apnea syndrome in the general population. Arch Iran Med. 2011 Sep;14(5):335–8. [PubMed] [Google Scholar]
- 2.Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep. 2010 Oct;33(10):1373–80. doi: 10.1093/sleep/33.10.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Khazaie H, Maroufi A. Obstructive sleep apnea syndrome; a neglected cause of traffic collision among Iranian public transport drivers. J Inj Violence Res. 2014 Jul;6(2):99. doi: 10.5249/jivr.v6i2.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Rodenstein D. Cost-B26 Action on Sleep Apnoea Syndrome. Driving in Europe: the need of a common policy for drivers with obstructive sleep apnoea syndrome. J Sleep Res. 2008 Sep;17(3):281–4. doi: 10.1111/j.1365-2869.2008.00669.x. [DOI] [PubMed] [Google Scholar]
- 5.Bonsignore MR, Randerath W, Riha R, Smyth D, Gratziou C, Gonçalves M, et al. New rules on driver licensing for patients with obstructive sleep apnea: European Union Directive 2014/85/EU. J Sleep Res. 2016 Feb;25(1):3–4. doi: 10.1111/jsr.12379. [DOI] [PubMed] [Google Scholar]
- 6.Watkins MR, Talmage JB, Thiese MS, Hudson TB, Hegmann KT. Correlation between screening for obstructive sleep apnea using a portable device versus polysomnography testing in a commercial driving population. J Occup Environ Med. 2009 Oct;51(10):1145–50. doi: 10.1097/JOM.0b013e3181b68d52. [DOI] [PubMed] [Google Scholar]